Non-Hodgkin's lymphoma refractory

• A Phase 1/2, Open-Label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Antineoplastic Activity of IPH6501 in Pat … Ended
  2023-506976-28-00 9 2024-05-16 "Relapsed and/or Refractory CD20-expressing Non-Hodgkin Lymph"
• Study of safety and preliminary efficacy of VAY736 given alone or in combination with other antineoplastic agents in patients with NHL Ended
  2024-511489-35-00 3 2022-01-24 "Relapsed/refractory Non Hodgkin Lymphoma"
• This is clinical study to test, for the first time in people, the safety (any good or bad effects), how long the drug can stay in the body a … Ended
  2023-509969-20-00 1 2017-07-24 "Part C: advanced or unresectable STs (Spain only)"

Showing 1–3 of 3 trials